Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer
about
miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25"Upstream Analysis": An Integrated Promoter-Pathway Analysis Approach to Causal Interpretation of Microarray Data.USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition.Ubiquitin-specific peptidase 22, a histone deubiquitinating enzyme, is a novel poor prognostic factor for salivary adenoid cystic carcinoma.High USP22 expression indicates poor prognosis in hepatocellular carcinoma.Deubiquitinases in cancer.Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma.Ubiquitin specific peptidase 5 mediates Histidine-rich protein Hpn induced cell apoptosis in hepatocellular carcinoma through P14-P53 signaling.Impact of Histochemistry on biomedical research: looking through the articles published in a long-established histochemical journal.Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma.Histochemistry as an irreplaceable approach for investigating functional cytology and histology.ATXN7L3 and ENY2 Coordinate Activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor Growth.Prognostic and clinicopathological significance of ubiquitin-specific protease 22 overexpression in cancers: evidence from a meta-analysis.Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma.Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-initiating Cells from Lung Adenocarcinoma.High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis.
P2860
Q28390685-5989FDD3-BDC0-4A70-A15A-E8FA39BAB829Q31126994-F0677429-6A0F-4C01-A2DD-3C5464FB2786Q35016431-01F877E8-C65A-4E33-80F5-8ED02FC9E6D7Q35086256-650F9387-099D-4E91-8F33-9CD8A963C06CQ35828647-FEF0F570-1B57-4056-BC5D-C80181FAD652Q35955141-B29F0F14-96CD-4417-9082-6C4917E81AF2Q37327698-E85F6664-8461-4F12-81D8-D5ECC03593E1Q40206338-0BE1D93A-1DFA-42A7-A7A8-C18614ACEAE9Q41595424-4F041D2B-3149-42D6-853A-6785D88F47C2Q41612309-578945C4-74F2-44EE-87C9-AD14FBD9C620Q41836330-A80BC8A7-4224-4B3E-9ACE-575BB40F16FBQ42772802-675EABDE-3950-4D8E-B6D6-39C922324E8CQ47108513-D0E98694-6BF4-40E4-912B-E3FCE2473E0EQ47576205-6166446E-BE82-470F-BA6A-446365CBE433Q52714520-08D357C9-DE08-45E2-A9AE-D0D1D16CA4E2Q55387283-82B7F7FF-8D3F-4EE2-8BA4-F9A93EF1EAF0
P2860
Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Overexpression of ubiquitin-sp ...... age non-small cell lung cancer
@ast
Overexpression of ubiquitin-sp ...... age non-small cell lung cancer
@en
type
label
Overexpression of ubiquitin-sp ...... age non-small cell lung cancer
@ast
Overexpression of ubiquitin-sp ...... age non-small cell lung cancer
@en
prefLabel
Overexpression of ubiquitin-sp ...... age non-small cell lung cancer
@ast
Overexpression of ubiquitin-sp ...... age non-small cell lung cancer
@en
P2093
P2860
P356
P1476
Overexpression of ubiquitin-sp ...... age non-small cell lung cancer
@en
P2093
P2860
P356
10.4081/EJH.2012.E46
P577
2012-11-30T00:00:00Z